Additionally, studies in mice have shown that enhanced expression of PPM1D increases the onset of ERBB2-induced mammary gland tumors [38] and also increases the incidence of SHH-driven medulloblastomas [39]. This evidence concerns the gene PPM1D and medulloblastoma.